Platelet depletion does not alter long-term functional outcome after cerebral ischaemia in mice.

Behaviour Cerebral ischaemia Long-term Platelet depletion Platelets Recovery Stroke Transient middle cerebral artery occlusion tMCAO

Journal

Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 20 05 2022
revised: 11 07 2022
accepted: 18 07 2022
entrez: 5 8 2022
pubmed: 6 8 2022
medline: 6 8 2022
Statut: epublish

Résumé

Platelets are key mediators of thrombus formation and inflammation during the acute phase of ischaemic stroke. Particularly, the platelet glycoprotein (GP) receptors GPIbα and GPVI have been shown to mediate platelet adhesion and activation in the ischaemic brain. GPIbα and GPVI blockade could reduce infarct volumes and improve functional outcome in mouse models of acute ischaemic stroke, without concomitantly increasing intracerebral haemorrhage. However, the functional role of platelets during long-term stroke recovery has not been elucidated so far. Thus, we here examined the impact of platelet depletion on post-stroke recovery after transient middle cerebral artery occlusion (tMCAO) in adult male mice. Platelet depleting antibodies or isotype control were applied from day 3-28 after tMCAO in mice matched for infarct size. Long-term functional recovery was assessed over the course of 28 days by behavioural testing encompassing motor and sensorimotorical functions, as well as anxiety-like or spontaneous behaviour. Whole brain flow cytometry and light sheet fluorescent microscopy were used to identify resident and infiltrated immune cell types, and to determine the effects of platelet depletion on the cerebral vascular architecture, respectively. We found that delayed platelet depletion does not improve long-term functional outcome in the tMCAO stroke model. Immune cell abundance, the extent of thrombosis and the organisation of the cerebral vasculature were also comparable between platelet-depleted and control mice. Our study demonstrates that, despite their critical role in the acute stroke setting, platelets appear to contribute only marginally to tissue reorganisation and functional recovery at later stroke stages.

Identifiants

pubmed: 35928516
doi: 10.1016/j.bbih.2022.100493
pii: S2666-3546(22)00083-7
pmc: PMC9343933
doi:

Types de publication

Journal Article

Langues

eng

Pagination

100493

Informations de copyright

© 2022 The Authors.

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Références

J Neurosci Methods. 2013 Mar 15;213(2):179-87
pubmed: 23291083
Brain Behav Immun. 2018 Mar;69:255-263
pubmed: 29195783
Transfus Med Rev. 2010 Jul;24(3):218-34
pubmed: 20656189
Circulation. 2007 May 1;115(17):2323-30
pubmed: 17438148
Brain Behav Immun. 2021 Mar;93:288-298
pubmed: 33401017
J Cereb Blood Flow Metab. 2017 Nov;37(11):3488-3517
pubmed: 28797196
ScientificWorldJournal. 2014 Mar 03;2014:781857
pubmed: 24729754
Exp Neurol. 2014 Nov;261:417-23
pubmed: 25058045
Inflamm Bowel Dis. 2004 Jul;10(4):361-72
pubmed: 15475744
Sci Rep. 2021 Nov 24;11(1):22887
pubmed: 34819574
Thromb Haemost. 2013 Aug;110(2):323-30
pubmed: 23765126
J Neuroinflammation. 2019 Jul 10;16(1):142
pubmed: 31291966
Psychopharmacology (Berl). 1987;92(2):180-5
pubmed: 3110839
Methods Mol Biol. 2019;1916:99-103
pubmed: 30535687
Curr Neurovasc Res. 2012 Aug;9(3):185-92
pubmed: 22621230
J Thromb Haemost. 2015 Feb;13(2):303-13
pubmed: 25418277
Exp Neurol. 2021 Oct;344:113804
pubmed: 34237320
Transl Stroke Res. 2021 Dec;12(6):976-990
pubmed: 33496918
J Infect Dis. 2019 Jan 29;219(4):648-659
pubmed: 30312422
Stroke. 1986 May-Jun;17(3):472-6
pubmed: 3715945
Cerebrovasc Dis. 2009;28(3):276-82
pubmed: 19609079
Br J Pharmacol. 2015 Aug;172(15):3904-16
pubmed: 25917571
Nat Commun. 2021 Jun 7;12(1):3352
pubmed: 34099640
Int J Mol Sci. 2019 Apr 24;20(8):
pubmed: 31022936
Front Immunol. 2019 Nov 01;10:2505
pubmed: 31736950
Semin Immunol. 2018 Jun;37:43-52
pubmed: 29426568
Nat Protoc. 2007;2(2):322-8
pubmed: 17406592
Circ Res. 2020 Sep 25;127(8):1023-1035
pubmed: 32762491
Blood Rev. 2015 May;29(3):153-62
pubmed: 25468720
Pharmacol Biochem Behav. 1978 Jan;8(1):101-2
pubmed: 625478
Pharmacol Biochem Behav. 1982 Mar;16(3):455-62
pubmed: 7079281
PLoS Biol. 2010 Jun 29;8(6):e1000412
pubmed: 20613859
Brain Pathol. 2013 Jan;23(1):34-44
pubmed: 22775530
Stem Cell Reports. 2019 Apr 9;12(4):667-679
pubmed: 30905740
Behav Brain Res. 2018 Jan 15;336:250-255
pubmed: 28893552
Stroke. 2021 Oct;52(10):3082-3087
pubmed: 34465201
J Neurosci Methods. 2018 Apr 15;300:26-36
pubmed: 28414048
Stroke. 2015 Dec;46(12):3502-6
pubmed: 26486866
Front Genet. 2019 Feb 11;9:598
pubmed: 30809253
J Neuroinflammation. 2017 Jan 21;14(1):18
pubmed: 28109273
J Clin Med. 2019 Feb 01;8(2):
pubmed: 30717130
PLoS One. 2014 Sep 19;9(9):e107503
pubmed: 25238071
Front Immunol. 2020 Oct 06;11:548631
pubmed: 33123127
Hamostaseologie. 2020 Jun;40(2):153-164
pubmed: 32455457
J Immunol. 2022 Apr 1;208(7):1729-1741
pubmed: 35277420
J Pharm Pharmacol. 1968 Apr;20(4):302-4
pubmed: 4384609
Front Cell Neurosci. 2021 Jan 05;14:625513
pubmed: 33469420
Pharmacotherapy. 2021 Oct;41(10):828-836
pubmed: 34478577
Ann Neurol. 2020 Jan;87(1):40-51
pubmed: 31714631
Lancet Neurol. 2019 May;18(5):439-458
pubmed: 30871944
Stroke. 2009 May;40(5):1849-57
pubmed: 19265055
Front Immunol. 2018 Nov 20;9:2712
pubmed: 30515177
Exp Neurol. 2016 Sep;283(Pt A):264-75
pubmed: 27349408
Sci Rep. 2021 Jun 3;11(1):11663
pubmed: 34083615
Int J Lab Hematol. 2013 Jun;35(3):254-61
pubmed: 23590652
J Exp Med. 2021 Aug 2;218(8):
pubmed: 34037669
Exp Neurol. 2007 Feb;203(2):555-67
pubmed: 17067578

Auteurs

Rebecca D Steubing (RD)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Fabian Szepanowski (F)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Christina David (C)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Ayan Mohamud Yusuf (A)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Stine Mencl (S)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Anne-Kathrin Mausberg (AK)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Harald F Langer (HF)

University Hospital, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.

Manuela Sauter (M)

University Hospital, Medical Clinic II, University Heart Center Lübeck, Lübeck, Germany.

Cornelius Deuschl (C)

Department of Radiology, University Medicine Essen, Essen, Germany.

Michael Forsting (M)

Department of Radiology, University Medicine Essen, Essen, Germany.

Anke C Fender (AC)

Institute of Pharmacology, University Medicine Essen, Essen, Germany.

Dirk M Hermann (DM)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Ana I Casas (AI)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Friederike Langhauser (F)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Christoph Kleinschnitz (C)

Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, Essen, Germany.

Classifications MeSH